Despite the fact that higher levels of serum TXNIP are observed in the renal tissues of diabetic kidney disease patients [50,51], drugs are currently not readily available to control DN development through the suppression of TXNIP. This evidence concerns the gene TXNIP and diabetic kidney disease.